Find the drug and healthcare news of the USA and Canada.
FDA Devices Approval | 2024 | Abbott News | iPharmaCenter
FDA Diagnostics Approvals | 2024 | FDA Approvals | iPharmaCenter
Centers for Disease Control and Prevention | CDC | iPharmaCenter | 2024
Express-Scripts | Pharmacy Benefit Manager | News | Updates | 2024 | US Healthcare | iPharmaCenter
Eisai's Leqembi received FDA approval for Alzheimer's | CMS coverage of Leqembi | ipharmacenter
COVID19 drug updates | FDA EMA approved COVID19 drugs
Genzyme's Xenpozyme approved for Acid Sphingomyelinase Deficiency | iPharmaCenter
Lilly's and Incyte's Olumiant approved for adults with severe alopecia areata
Myasthenia Gravis News | FDA and EMA approvals |
American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates
FDA approved Novartis Scembli for chronic myeloid leukemia
Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval
GSK’s Jemperli received approval in Europe and the US for endometrial cancer
BMS’ and bluebird bio’s Abecma approved by US FDA; first CAR T cell therapy for multiple myeloma
Novartis’ blockbuster Entresto received the US FDA approval for a broader target population